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Abstract
Background: The global predominance of tuberculosis in men has received significant attention. However,
epidemiological studies now demonstrate that there is an increased representation of young women with
tuberculosis, especially in high HIV burden settings where young women bear a disproportionate burden of
HIV. The role of the HIV epidemic, as well as changes in behavioural, biological, and structural risk factors are
explored as potential explanations for the increasing burden of tuberculosis in young women.
Discussion: As young women are particularly vulnerable to HIV infection in sub-Saharan Africa, it is unsurprising that the
TB epidemic in this setting has become increasingly feminised. This age-sex trend of TB in South Africa is similar to WHO
estimates for other countries with a high HIV prevalence where there are more female than male cases notified up to the
age of 25 years. The high prevalence of anaemia of chronic disease in young women with HIV is an additional potential
reason for their increased TB risk. The widespread use of injectable medroxyprogesterone acetate contraception, which has
been shown to possess selective glucocorticoid effect and oestrogen suppression, in young women may be an important
emerging biological risk factor for tuberculosis in young women. Behavioural factors such as alcohol use and tobacco
smoking patterns are further factors which may be responsible for the narrowing of the sex gap in TB epidemiology. In
comparison to the significantly higher alcohol consumption rates in men globally, there is a narrowing gap in alcohol
consumption between the sexes in South Africa with alarming rates of alcohol abuse in young women. There is
a similar narrowing of the tobacco smoking gap between the sexes in South Africa, with increasing smoking
prevalence in young women.
Conclusion: With nearly 70% of all TB patients being co-infected with HIV in our setting, it is not surprising
that the age and sex distribution of TB is increasingly resembling the distribution of HIV in this region of dual
hyperendemicity. New TB service design must begin to reflect the presence of young women as a significant
group burdened by the disease.
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Background
With a global incidence of 13.4 million new cases in
2015, tuberculosis remains a public health priority which
demands our ongoing efforts toward its successful con-
trol [1]. In South Africa, tuberculosis is now the leading
cause of death, fuelled by a burgeoning HIV epidemic
[2]. Unlike HIV programmes, TB control efforts have
not enjoyed a similar focus on key populations, and a
detailed understanding of local disease epidemiology has
been substituted for a uniform public health strategy.
However, there has been renewed interest in deepening
our understanding of the disease epidemiology especially
with regard to sex differences. In contrast to the signifi-
cant attention that has been given to the global predom-
inance of tuberculosis in men, there has been a paucity
of focus on the burden of disease in young women,
particularly in high TB/HIV burden settings. In this art-
icle we argue that there is an increasing burden of TB in
young women in high HIV burden settings resulting
from biological, behavioural and structural risk factors
which require further evaluation. The opportunity to re-
design TB services so that it appropriately responds the
needs of young women is also explored.
Discussion
The excess of notified cases among men has been explained
by increased transmission between men, the increased
prevalence of proximate risk factors for TB such as smok-
ing and alcohol use, specific immunological vulnerabilities
in men, barriers faced by women in seeking care and pre-
senting for diagnosis, and most recently, biological predis-
positions in men related to iron metabolism [3–6].
Although sex disaggregation of global and local tuberculosis
data is an important starting point for unpacking TB epi-
demiology, age-specific sex ratios may offer more useful in-
sights into local disease epidemiology and should serve as
the basis for health system planning. While the overall
male: female(M:F) TB prevalence ratio was 2.21 for bac-
teriologically positive tuberculosis in low and middle-
income countries, the age-specific sex ratios ranged from 1.
28 among individuals aged 15–24 years to 3.18 among indi-
viduals aged 45–54 years in a recent meta-analysis [7].
Moreover, M: F TB prevalence ratios were lower, and dem-
onstrated a female predominance, in settings of high HIV
prevalence (0.67, 95% CI 0.49–0.90; 54 surveys). The spe-
cific exclusion of studies in HIV sub-populations in the
meta-analysis, results in a failure to reflect the epidemio-
logical nuances in high TB/HIV burden settings. Import-
antly, seven out of the top 20 high TB/HIV burden
countries (six out of the seven being African countries)
were not represented in the meta-analysis, likely as a result
of the lack of high quality epidemiological studies in these
parts of the world. As young women are particularly vul-
nerable to HIV infection in sub-Saharan Africa, it is
unsurprising that the TB epidemic in this setting has be-
come increasingly feminised.
There have been several studies evaluating the factors
which may contribute to the under-representation of
women in epidemiological assessments of tuberculosis.
The study of only bacteriologically proven tuberculosis,
as is the case with the meta-analysis by Horton et al.,
systematically under-represents women who are more
likely to be sputum non-producers and are more likely
to experience smear-negative tuberculosis than their
male counterparts [8, 9]. This is of heightened import-
ance in studies conducted prior to the programmatic
rollout of Xpert MTB/RIF, when sputum microscopy
served as the primary microbiological basis for the diag-
nosis of tuberculosis in many low and middle income
countries. The exclusion of studies employing active case
finding or enhanced case finding may have also contrib-
uted to the exclusion of a disproportionately greater
number of female cases of TB as active case finding has
been demonstrated to identify a greater number of
young women with HIV-associated TB [10]. An add-
itional reason for the under-representation of women
with TB in epidemiological studies is the greater number
of missed tuberculosis cases in women despite their con-
tact with health systems. TB symptom screening – a key
component of intensified case finding - has also been
shown to be of limited value in HIV-positive women,
especially pregnant women, and missed 72% of cases of
asymptomatic prevalent TB [11].
Heavy alcohol use has a complex and detrimental
effect on systemic and lung immunity predisposing alco-
hol abusers to the acquisition of tuberculosis. The global
pattern of significantly higher rates of drinking among
men has been suggested as one of the factors resulting
in a male predominance of TB. It is, however, alarming
that while men have a higher overall prevalence of alco-
hol use in South Africa, this consumption gap is narrow-
ing [12]. Although the per capita alcohol consumption
in sub-Saharan Africa are similar to global averages, the
region also has one of the highest rates of abstinence
from alcohol, with very high levels of consumption
amongst those who do drink [13]. In the Western Cape
province of South Africa, where some of the highest in-
cidence rates of TB occur, 34% of urban and 46–51% of
rural women drink during pregnancy, effectively closing
the drinking gap between these young women and their
male counterparts [14]. Differential patterns of smoking
between sexes have been postulated to explain up to one
third of the sex differences seen in global TB epidemi-
ology [15]. While smoking is still twice as common in
South African men than women, the only group with an
increasing smoking prevalence are young, educated
(>grade 12) women in the setting of urbanisation [16].
These patterns of alcohol and smoking use may well be
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contributing to the narrowing of the sex gap in local TB
epidemiology.
Studies of hormonal mechanisms and TB suggest the
protective effect of oestrogen and the potentially deleterious
effect of medroxyprogesterone acetate on TB acquisition
and disease control. A murine model with comparable
serum concentrations as injectable medroxyprogesterone
acetate contraception demonstrated significant glucocortic-
oid effect, and significantly increased risk of TB acquisition
and reduced control of TB disease [17]. A similarly in-
creased immunological vulnerability to TB was demon-
strated in an in vitro human study on the effect of
progesterone contraception on immunological correlates of
TB risk [18]. The widespread use of the progesterone
contraceptive Depo-Provera in South Africa may be con-
tributing to a loss of oestrogenic protection and an
increased glucocorticoid effect in South African women,
conferring an increased risk of TB [17, 19]. Importantly
almost half of all women of child-bearing age are on
contraception in South Africa, and the use of injectable
progesterone contraception is now the most commonly
used method of contraception, especially amongst young
women [19]. The popularity of this form of injectable
contraception has an appeal to young women the world
over because, apart from its efficacy, it requires only four
clinic visits per year and obviates the need for a daily oral
contraceptive. Androgen deprivation by castration in male
mice leads to an increase in T-lymphocytes in lymph nodes
and increased proliferation of these cells when activated by
antigenic stimulation [20]. Further, epidemiological evi-
dence of oestrogenic protection is revealed by studies which
demonstrate significantly poorer TB outcomes in intact
men compared to castrated men, and increased TB mortal-
ity in women who underwent oophorectomy [21, 22]. Key
postulates are that oestrogen supports the activation of
macrophages, a key component of the immunological con-
trol of TB, and that oestrogen plays an important role in
amplifying interferon-gamma secretion by activated natural
killer T-cells [23]. The effect of ovarian follicular stag-
nation and resultant hypooestrogenism by long term
medroxyprogesterone acetate exposure has been dem-
onstrated, and implications for oestrogen sensitive tis-
sues such as components of the immune system
require further evaluation [24, 25]. The protective role
of oestrogen, mediated through its synergism with
interferon-gamma production, against pathogens such
as Coxiella, Leishmania, and other mycobacteria have
been previously reported [26–28]. Serum oestrogen
levels in long term injectable progesterone contracep-
tive users may be as low as the post-menopausal
range, and may be plausibly linked to the loss of the
protective benefit of oestrogen on TB acquisition and
disease control in these, predominantly young,
women. These sex-hormone effects on TB risk are
supported by the highest M:F ratios during the reproduct-
ive years in women globally, while the sex ratio approxi-
mates 1:1 in the pre-pubescent age group [4, 29].
Even in the face of a global predominance of TB in
men, it cannot be ignored that TB/HIV co-infected
women experience mortality rates that are 20% higher
than TB/HIV co-infected men [30]. The global and local
epidemiology of TB has shifted over the decades with
the advent of HIV from being a disease with historically
increased prevalence in men, and in those at the
extremes of age, to one of increasing prevalence in
women [1]. This shifting demographic feature has not
been accounted for in health system planning activities,
with little emphasis on making tuberculosis facilities
more women’s health friendly. This is particularly
important in sub-Saharan Africa where the local tuber-
culosis epidemiology has been shaped by the intervening
HIV epidemic, and the disproportionate burden of HIV
in young women. HIV is now widely recognised as the
most potent risk factor for the development of tubercu-
losis disease, with a 21–34 times higher risk of tubercu-
losis in people living with HIV [1]. We previously
reported a female predominance of tuberculosis in
adults under 30 years of age in Durban, South Africa, an
epidemiological effect which was greater in the HIV
positive subset of patients [31]. The inference is that the
well documented higher prevalence of HIV in young
women compared to men is driving the increased preva-
lence of tuberculosis in this group, resulting in the fem-
inisation of the TB epidemic in young patients in this
setting. A previous study in this setting demonstrated a
significantly higher burden of TB disease among women
in the 20 to 29 years age group, in keeping with predic-
tions by mathematical models on the impact of HIV on
TB in areas of dual hyperendemicity [32]. In addition,
patients under the age of 30 years constitute approxi-
mately a third of all patients with tuberculosis locally.
While the overall global male predominance of tuber-
culosis requires greater attention, it is essential that we
do not neglect the growing number of young women
with tuberculosis, especially given their unique socio-
economic vulnerability in low and middle-income
countries. Unpublished programmatic data from an
urban tuberculosis facility in Durban, South Africa
(Ethical approval from the University of KwaZulu-Natal
Biomedical Research Ethics Committee, BFC031/08)
demonstrates that the proportion of women with tuber-
culosis aged 20–39 years has steadily increased, in
keeping with the increase in HIV prevalence among
young women (Fig. 1).
This age-sex trend of TB in South Africa is similar to
WHO estimates for other African countries with a high
HIV prevalence where there are more female than male
cases notified up to the age of 25 years [33]. Importantly,
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in low income countries TB kills more women than all
causes of maternal mortality combined. Young women
have up to 34% higher risk of progression to TB disease
than men up to the age of 30 years attributed to reduced
immunity associated with the stresses of pregnancy [34].
In addition, young women have lower cumulative TB
infections in adolescence, inferring that new post-
adolescence infection might be significantly greater
amongst women. New infection with TB carries a
greater likelihood to progress to TB disease, and to
do so more rapidly.
Iron is a critical element for the survival and prolifera-
tion of Mycobacterium tuberculosis [35]. More than 80%
of patients with HIV associated TB are anaemic in South
Africa, with over 95% of these cases resulting from
anaemia of chronic disease [36]. This form of anaemia is
characterised by an elevation of the iron-gating hormone
hepcidin, which traps iron within the reticuloendothelial
system and macrophages [37]. Macrophage iron loading
may confer an increased risk for TB acquisition and pro-
gression to disease by providing an essential substrate
for the organism’s survival and growth. The dispropor-
tionate burden of iron-deficiency anaemia in women of
reproductive age, due largely to menstrual losses, has
been cited as a factor conferring protection from TB in
women and potentially explains the male predominance
of TB globally in these age groups. However, in high
HIV burden settings, the prevalence of anaemia of
chronic disease is high with a significantly increased bur-
den of this type of anaemia in women compared to men
[38]. It is possible that the high burden of anaemia of
chronic disease in women with HIV reduces the protec-
tion from TB that accrues from iron-deficiency, and
moreover that macrophage iron loading in these women
increases their risk of TB. Importantly, anaemia may
ensue early after HIV acquisition, and may represent the
initial effects of hepcidin elevation during the period of
sustained systemic inflammation following acute HIV
infection [39]. These factors support the hypothesis that
iron loading of macrophages in young women, who bear
the greatest burden of incident HIV in sub-Saharan
Africa, are at an increased risk for TB disease, and may
explain the lower M:F TB ratios in high HIV burdened
settings in sub-Saharan Africa.
A growing recognition of the gradually changing
face of TB will allow for the exploitation of the op-
portunities presented by this evolving epidemiology.
The broadening of services may serve to appropriately
orientate existing TB services with regards to the
changing demographic profile of patients, to augment
women’s health services, to respond to the need for
comprehensive primary health care services, and most
importantly, to acknowledge the presence of multiple
pathologies in an individual patient that cannot
adequately be addressed by a vertical programme de-
sign. This might include access to family planning,
pap smear evaluations, and targeted interventions for
young women such as microbicide gels in future.
Conclusions
The problem of TB/HIV co-infection is not a homogenous
entity, but rather a composite of many complex sub-
epidemics. This is largely due to the various drivers of
HIV and TB which have differential effects on various
strata of the population, most notably sub-populations by
age and sex. A key component of our response to tubercu-
losis must be our attention to the complexity of our local
epidemics. With nearly 70% of all TB patients being co-
infected with HIV in our setting, it is not surprising that
the age and sex distribution of TB is increasingly resem-
bling the distribution of HIV in this region of dual hyper-
endemicity. Whether this is due to behavioural, biological
or structural reasons is still uncertain, but the greater rep-
resentation of women at TB facilities in high HIV burden
settings has multiple programmatic implications. A more
comprehensive women-friendly service may lead to
Fig. 1 Proportions of men and women with sputum positive tuberculosis aged 20 to 39 years at an urban facility in Durban, South Africa during
the period 1998 to 2011. Unpublished review of programmatic data from an urban TB clinic in Durban, South Africa (Ethical approval BFC031/08)
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greater public access, more equitable access for all pa-
tients, a more convenient and satisfying service, and better
health overall. New TB service design must begin to re-
flect the presence of young women as a significant group
burdened by the disease.
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